{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:08:44Z","timestamp":1784833724724,"version":"3.55.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["R01EY031097"],"award-info":[{"award-number":["R01EY031097"]}]},{"name":"National Institute of Health","award":["R37CA246699"],"award-info":[{"award-number":["R37CA246699"]}]},{"name":"National Institute of Health","award":["P41EB024495"],"award-info":[{"award-number":["P41EB024495"]}]},{"name":"National Institute of Health","award":["R01CA228133"],"award-info":[{"award-number":["R01CA228133"]}]},{"name":"National Institute of Health","award":["P41EB028239"],"award-info":[{"award-number":["P41EB028239"]}]},{"name":"Goldhirsh-Yellin Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The objective of this study was to create and evaluate episomal plasmids for use in non-viral polymeric gene delivery to cancer cells. A comparative analysis was conducted utilizing poly(beta-amino ester)s (PBAEs) as the nanocarrier vector and various hepatocellular carcinoma (HCC) and brain cancer cell lines. A total of fourteen reporter plasmids that varied in promoter (CMV, CAG, EF1\u03b1), backbone (Z1, pUNO1, Nanoplasmid [NanoP]), length (~2000 to ~7000 base-pairs), and antibiotic selection marker (Kanamycin, Zeocin, Blasticidin, or none) were constructed, characterized, and evaluated for gene delivery performance. GFP and mCherry plasmids were evaluated in six HCC lines: human (Hep3B), murine (Hepa1\u20136, Hepa1c1c7), and porcine (A92, A272, B239). Luciferase plasmid constructs were evaluated in three brain cancer lines: murine glioma (CT-2A), human astrocytoma (CCF-STTG1), and human meningioma (IOMM-Lee). When comparing promoters within the same backbone (Z1), the GFP nanoparticles (NPs) under control of a CMV promoter demonstrated consistently higher expression than those with a CAG or EF1\u03b1 promoter. As EF1\u03b1 promoters are often used for\n                    <jats:italic>in vivo<\/jats:italic>\n                    applications due to their resistance to gene silencing, four GFP plasmids under control of the EF1\u03b1 promoter were also compared: Z1-EF1\u03b1-GFP, pUNO1-GFP, pUNO1-GFP-SV40, and NanoP-GFP. Of these, the NPs delivering NanoP-GFP, a minimal plasmid, resulted in the highest %GFP+ cells in five HCC cell lines, the highest GFP geometric mean fluorescence intensity (gMFI) in all six HCC cell lines, and the highest luciferase signal in two out of three brain cancer cell lines. NanoP was also the only plasmid evaluated without an antibiotic resistance gene, which may be advantageous when selecting a plasmid best able to meet regulatory guidance for clinical translation. Finally, a modest negative correlation between plasmid size and either transfection efficacy or GFP gMFI was observed. Overall, this work helps to inform episomal plasmid design strategy for use with non-viral gene therapies.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0352468","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:57:21Z","timestamp":1784833041000},"page":"e0352468","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0455-0635","authenticated-orcid":true,"given":"Joanna","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Kollings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Idnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella G.","family":"Cozzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanelle","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahita","family":"Varanasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany Y.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"2","key":"pone.0352468.ref001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrm3738","article-title":"Synthetic biology in mammalian cells: next generation research tools and therapeutics","volume":"15","author":"F Lienert","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pone.0352468.ref002","article-title":"The art of vector engineering: towards the construction of next\u2010generation genetic tools","year":"2019","journal-title":"Microbial Biotechnology"},{"issue":"5","key":"pone.0352468.ref003","article-title":"Systematic comparison of constitutive promoters and the doxycycline-inducible promoter","volume":"5","author":"JY Qin","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"pone.0352468.ref004","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202500475","article-title":"DNA-loaded nanoparticles reprogram the tumor immune microenvironment to treat brain tumors","volume":"6","author":"J Yang","year":"2026","journal-title":"Small Sci"},{"issue":"7","key":"pone.0352468.ref005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"DW Pack","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0352468.ref006","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2147\/IJN.S390384","article-title":"Non-viral gene delivery to hepatocellular carcinoma via intra-arterial injection","volume":"18","author":"HJ Vaughan","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"pone.0352468.ref007","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/ar200248u","article-title":"Bioreducible Polymers for Gene Silencing and Delivery","volume":"45","author":"S Son","year":"2012","journal-title":"Acc Chem Res"},{"issue":"3","key":"pone.0352468.ref008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","article-title":"Gene therapy: advances, challenges and perspectives","volume":"15","author":"GAR Gon\u00e7alves","year":"2017","journal-title":"Einstein (Sao Paulo)"},{"issue":"1","key":"pone.0352468.ref009","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","article-title":"Emerging non-viral vectors for gene delivery","volume":"21","author":"C Wang","year":"2023","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"pone.0352468.ref010","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"HB El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"pone.0352468.ref011"},{"issue":"1","key":"pone.0352468.ref012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-025-01213-z","article-title":"Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma","volume":"10","author":"K Tang","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"pone.0352468.ref013","doi-asserted-by":"crossref","first-page":"1669236","DOI":"10.3389\/fbinf.2025.1669236","article-title":"Spatial heterogeneity reveals an evolutionary signature predicting therapeutic response and clinical outcomes in hepatocellular carcinoma","volume":"5","author":"S Luo","year":"2025","journal-title":"Front Bioinform"},{"key":"pone.0352468.ref014","article-title":"Carboxylated branched poly(\u03b2-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing","journal-title":"Science Advances"},{"issue":"18","key":"pone.0352468.ref015","doi-asserted-by":"crossref","DOI":"10.1021\/ja4002376","article-title":"The effect and role of carbon atoms in Poly(beta-amino ester)s for DNA binding and gene delivery","volume":"135","author":"CJ Bishop","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"7","key":"pone.0352468.ref016","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tibtech.2018.02.006","article-title":"Design of polymeric gene carriers for effective intracellular delivery","volume":"36","author":"W-F Lai","year":"2018","journal-title":"Trends Biotechnol"},{"issue":"7","key":"pone.0352468.ref017","article-title":"Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors","volume":"52","author":"IMS Degors","year":"2019","journal-title":"Acc Chem Res"},{"key":"pone.0352468.ref018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2020.06.014","article-title":"Polymeric vehicles for nucleic acid delivery","volume":"156","author":"AS Piotrowski-Daspit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"pone.0352468.ref019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.actbio.2016.03.036","article-title":"Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry","volume":"37","author":"CJ Bishop","year":"2016","journal-title":"Acta Biomater"},{"key":"pone.0352468.ref020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jconrel.2015.09.046","article-title":"Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles","volume":"219","author":"CJ Bishop","year":"2015","journal-title":"J Control Release"},{"issue":"29","key":"pone.0352468.ref021","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo6406","article-title":"Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma","volume":"8","author":"HJ Vaughan","year":"2022","journal-title":"Sci Adv"},{"issue":"10","key":"pone.0352468.ref022","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl3576","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes","volume":"10","author":"J Shen","year":"2024","journal-title":"Sci Adv"},{"issue":"10","key":"pone.0352468.ref023","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/17425247.2020.1796628","article-title":"Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities","volume":"17","author":"J Karlsson","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"key":"pone.0352468.ref024","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.2147\/IJN.S377371","article-title":"Poly(Beta-Amino Ester)s as high-yield transfection reagents for recombinant protein production","volume":"17","author":"KM Luly","year":"2022","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"pone.0352468.ref025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/ar7002336","article-title":"A combinatorial polymer library approach yields insight into nonviral gene delivery","volume":"41","author":"JJ Green","year":"2008","journal-title":"Acc Chem Res"},{"key":"pone.0352468.ref026","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2017.03.384","article-title":"Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma","volume":"263","author":"CG Zamboni","year":"2017","journal-title":"J Control Release"},{"issue":"5","key":"pone.0352468.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037543","article-title":"Poly(\u03b2-Amino Ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo","volume":"7","author":"JC Sunshine","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"pone.0352468.ref028","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl3576","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes","volume":"10","author":"J Shen","year":"2024","journal-title":"Sci Adv"},{"issue":"2","key":"pone.0352468.ref029","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1039\/D5SC05951H","article-title":"Poly(beta-amino esters): applications in immunology","volume":"17","author":"H Bayraktutan","year":"2025","journal-title":"Chem Sci"},{"issue":"29","key":"pone.0352468.ref030","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo6406","article-title":"Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma","volume":"8","author":"HJ Vaughan","year":"2022","journal-title":"Sci Adv"},{"key":"pone.0352468.ref031"},{"issue":"22","key":"pone.0352468.ref032","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1093\/nar\/9.22.6047","article-title":"The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants","volume":"9","author":"P Moreau","year":"1981","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0352468.ref033","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/excr.1999.4716","article-title":"Sequence requirements for plasmid nuclear import","volume":"253","author":"DA Dean","year":"1999","journal-title":"Exp Cell Res"},{"issue":"10","key":"pone.0352468.ref034","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1128\/jvi.61.10.2973-2980.1987","article-title":"Effects of position and orientation of the 72-base-pair-repeat transcriptional enhancer on replication from the simian virus 40 core origin","volume":"61","author":"SC Chandrasekharappa","year":"1987","journal-title":"J Virol"},{"issue":"2","key":"pone.0352468.ref035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/excr.1999.4716","article-title":"Sequence requirements for plasmid nuclear import","volume":"253","author":"DA Dean","year":"1999","journal-title":"Exp Cell Res"},{"issue":"2","key":"pone.0352468.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171257","article-title":"Engineering of mCherry variants with long Stokes shift, red-shifted fluorescence, and low cytotoxicity","volume":"12","author":"Y Shen","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"pone.0352468.ref037","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bio.729","article-title":"Imaging of luciferase and GFP-transfected human tumours in nude mice","volume":"18","author":"G Caceres","year":"2003","journal-title":"Luminescence"},{"issue":"11","key":"pone.0352468.ref038","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1271\/bbb.130537","article-title":"A comparison of Ypet and firefly luciferase as reporter proteins for high-throughput screening","volume":"77","author":"SM Yoon","year":"2013","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"pone.0352468.ref039","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ijms24010281","article-title":"Bioluminescent and fluorescent proteins: molecular mechanisms and modern applications","volume":"24","author":"ES Vysotski","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0352468.ref040","article-title":"Synthetic enhancers including TFREs improve transgene expression in CHO cells","volume":"10","author":"H-N Liu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"pone.0352468.ref041","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13036-019-0187-y","article-title":"Development of a new promoter to avoid the silencing of genes in the production of recombinant antibodies in chinese hamster ovary cells","volume":"13","author":"RA Z\u00fa\u00f1iga","year":"2019","journal-title":"J Biol Eng"},{"issue":"4","key":"pone.0352468.ref042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jgm.516","article-title":"Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle","volume":"6","author":"AR Brooks","year":"2004","journal-title":"J Gene Med"},{"key":"pone.0352468.ref043","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtm.2021.03.007","article-title":"Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo.","volume":"21","author":"JY Ho","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"pone.0352468.ref044","article-title":"Promoter choice: who should drive the CAR in T cells?","volume":"15","author":"SMAH Rad","year":"2020","journal-title":"PLoS One"},{"key":"pone.0352468.ref045","article-title":"Choosing the right tool for genetic engineering: clinical lessons from chimeric antigen receptor-T cells","journal-title":"Human Gene Therapy"},{"issue":"9","key":"pone.0352468.ref046","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/sj.mt.6300251","article-title":"Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells","volume":"15","author":"S Hong","year":"2007","journal-title":"Mol Ther"},{"issue":"11","key":"pone.0352468.ref047","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2","article-title":"Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma","volume":"89","author":"DI Tai","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"pone.0352468.ref048","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(02)00064-8","article-title":"Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas","volume":"37","author":"P Liu","year":"2002","journal-title":"J Hepatol"},{"key":"pone.0352468.ref049","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.actbio.2016.03.036","article-title":"Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry","volume":"37","author":"CJ Bishop","year":"2016","journal-title":"Acta Biomater"},{"issue":"4","key":"pone.0352468.ref050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/mt.2012.231","article-title":"Proteomic and functional analyses of protein-DNA complexes during gene transfer","volume":"21","author":"MA Badding","year":"2013","journal-title":"Mol Ther"},{"key":"pone.0352468.ref051","first-page":"477","article-title":"DNA nuclear targeting sequences for enhanced non-viral gene transfer: an in vitro and in vivo study. Mol Ther Nucleic Acids","volume":"24","author":"YT Le Guen","year":"2021"},{"issue":"9","key":"pone.0352468.ref052","first-page":"802","article-title":"Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer","volume":"3","author":"ZS Guo","year":"1996","journal-title":"Gene Ther"},{"key":"pone.0352468.ref053"},{"issue":"11","key":"pone.0352468.ref054","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1111\/jcmm.13216","article-title":"The EF-1\u03b1 promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells","volume":"21","author":"X Wang","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"7","key":"pone.0352468.ref055","article-title":"Promoter choice: who should drive the CAR in T cells?","volume":"15","author":"AHRS M","year":"2020","journal-title":"PLOS ONE"},{"issue":"6","key":"pone.0352468.ref056","article-title":"Cytoplasmic transport and nuclear import of plasmid DNA","volume":"37","author":"H Bai","year":"2017","journal-title":"Biosci Rep"},{"issue":"41","key":"pone.0352468.ref057","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1016\/j.vaccine.2012.02.061","article-title":"Scaling-up recombinant plasmid DNA for clinical trial: current concern, solution and status","volume":"30","author":"R Ismail","year":"2012","journal-title":"Vaccine"},{"key":"pone.0352468.ref058","unstructured":"Recommendations for microbial vectors used for gene therapy; guidance for industry. 2023."},{"key":"pone.0352468.ref059","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.omtn.2023.04.003","article-title":"Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors","volume":"32","author":"JA Williams","year":"2023","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:57:31Z","timestamp":1784833051000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352468"}},"subtitle":[],"editor":[{"given":"Chen","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352468","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}